KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) EPS (Basic) (2017 - 2025)

Historic EPS (Basic) for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$0.74.

  • Guardant Health's EPS (Basic) rose 1590.91% to -$0.74 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.21, marking a year-over-year increase of 2500.0%. This contributed to the annual value of -$3.56 for FY2024, which is 1693.65% up from last year.
  • Per Guardant Health's latest filing, its EPS (Basic) stood at -$0.74 for Q3 2025, which was up 1590.91% from -$0.8 recorded in Q2 2025.
  • Guardant Health's 5-year EPS (Basic) high stood at -$0.67 for Q2 2023, and its period low was -$2.25 during Q2 2022.
  • Over the past 5 years, Guardant Health's median EPS (Basic) value was -$0.94 (recorded in 2024), while the average stood at -$1.08.
  • As far as peak fluctuations go, Guardant Health's EPS (Basic) tumbled by 27586.21% in 2021, and later soared by 7022.22% in 2023.
  • Quarter analysis of 5 years shows Guardant Health's EPS (Basic) stood at -$0.89 in 2021, then tumbled by 53.93% to -$1.37 in 2022, then decreased by 18.25% to -$1.62 in 2023, then skyrocketed by 44.18% to -$0.9 in 2024, then increased by 18.17% to -$0.74 in 2025.
  • Its EPS (Basic) was -$0.74 in Q3 2025, compared to -$0.8 in Q2 2025 and -$0.77 in Q1 2025.